Reset Map4 Results
Unit 183, Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, E8 3FF United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Unit 183, Cambridge Science Park, Milton Road, Cambridge, Other, CB4 0GJ United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Unit 183, Cambridge Science Park, Milton Road Cambridge, Cambridgeshire, CB4 0GJ United KingdomOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
600 Park Offices Drive Suite 140 Research Triangle Park, NC, NC 27709 United StatesOwlstone Medical has developed and commercialized Breath Biopsy technology, a breathalyzer for disease capable of the reliable identification and analysis of biomarkers in exhaled breath, with the mission to become the global leader in non-invasive diagnostics for early detection and precision medicine. Breath Biopsy is now an established method that enables the reliable collection and analysis of a wide range of volatile organic compounds (VOCs) on human breath. The company has run the world’s largest breath based clinical trials and has established the first high volume breath analysis lab with ISO 9001 certification and quality checks at every stage of the workflow. In addition to capabilities around biomarker discovery and validation, Owlstone have also developed miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS) which have already been deployed for field based applications in military and industrial applications. Once suitable clinical biomarkers have been identified on breath, this same technology could be adapted as a cost effective, rapid, small footprint device for point of care or near patient testing. Finally, Owlstone is also developing methods for the collection and analysis of larger macro-molecules in exhaled breath aerosol including bacteria, viral particles and proteins. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort. Owlstone offers an end-to-end non-invasive biomarker service to pharmaceutical and academic partners from in vitro headspace analysis of VOCs from cell culture samples to clinical deployment of biomarkers on breath.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.